Submission for OMB Review; Generic Program-Specific Performance Progress Report (0970-0490), 68173-68174 [2019-26913]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 240 / Friday, December 13, 2019 / Notices
business days in advance at https://
www.cdc.gov/cancer/breast/what_cdc_
is_doing/conference.htm. Please
complete all the required fields before
submitting your registration and submit
no later than January 31, 2020.
Prevention and the Agency for Toxic
Substances and Disease Registry.
The meeting will be held on
February 6, 2020, 9:00 a.m. to 1:00 p.m.,
EST.
[FR Doc. 2019–26919 Filed 12–12–19; 8:45 am]
The meeting will be held by
teleconference and web conference. The
teleconference access is 1–888–606–
5944; and the passcode is 8340472. The
web conference access is https://
adobeconnect.cdc.gov/rwa641n3jrry/.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DATES:
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 5770 Buford Highway
NE, Mailstop S107–4, Atlanta, Georgia
30341; Telephone (770) 488–4518; Fax:
(770) 488–4760; Email: acbcyw@
cdc.gov.
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters To Be Considered: The agenda
will include discussions on current
topics related to breast cancer in young
women. These will include Mental/
Behavioral Health, Sexual Health,
Genetics and Genomics, and Provider
Engagement. Agenda items are subject
to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
17:42 Dec 12, 2019
Jkt 250001
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 4163–18–P
Administration for Children and
Families
Submission for OMB Review; Generic
Program-Specific Performance
Progress Report (0970–0490)
Office of Planning, Research,
and Evaluation; Administration for
Children and Families; HHS.
ACTION: Request for public comment.
AGENCY:
This Notice describes the
proposal to extend data collection under
the Administration for Children and
Families (ACF) Generic ProgramSpecific Performance Progress Report
(PPR) (0970–0490). This overarching
generic allows ACF program offices to
collect performance and progress data
from recipients and sub-recipients who
receive funding from ACF under a
discretionary grant or cooperative
agreement. This information is required
under 45 CFR 75.342, monitoring and
reporting program performance. The
generic program-specific PPR was
originally approved in January 2017.
DATES: Comments due within 30 days of
publication. OMB is required to make a
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Copies of the proposed collection may
be obtained by emailing
OPREinfocollection@acf.hhs.gov.
Alternatively, copies can also be
obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW,
SUMMARY:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
68173
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: ACF is primarily a grantmaking agency that promotes the
economic and social well-being of
families, children, individuals and
communities with partnerships,
funding, guidance, training and
technical assistance.
Prior to the use of this generic
program-specific PPR, a standard ACF
PPR (#0970–0406) was used for all ACF
discretionary grant and cooperative
agreement awards for post award
reporting. Historically, on the standard
ACF PPR form, ACF required grantees to
only respond to a common set of broad
questions, which often solicited
qualitative or incomplete information.
This one-size-fits-all approach did not
adequately collect the specific data
needed for particular grant programs or
allow program offices to assess
continuous quality improvement.
Different grant programs vary in
purpose, target population, and
activities. Therefore, a need for program
offices to customize performance
measurements was identified and the
generic program-specific PPR was
developed.
ACF program offices have benefited
from the ability to create and use a
program-specific PPR that is more
effective and includes specific data
elements that reflects a specific
program’s indicators, demographics,
priorities and objectives. This extension
includes extension of previously
approved program-specific PPRs under
this OMB #. A generic program-specific
PPR that can be tailored for programspecific needs allows program offices to
collect useful data in a uniform and
systematic manner. The reporting
format allows program offices to gather
uniform program performance data from
each grantee, allowing aggregation at the
program level to calculate outputs and
outcomes, providing a snapshot and
allowing for longitudinal analysis.
Data from a tailored program-specific
PPR that demonstrates a program’s
successes and challenges have been
useful for accountability purposes, such
as required reports to Congress.
Moreover, it has been useful for program
management and oversight, such as
identifying grantees’ technical
assistance needs and ensuring
compliance with Federal and
programmatic regulations and policies.
Respondents: ACF Grantees.
E:\FR\FM\13DEN1.SGM
13DEN1
68174
Federal Register / Vol. 84, No. 240 / Friday, December 13, 2019 / Notices
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hour
per
response
Total burden
hours
New Program Specific PPRs ...........................................................................
600
2
4
4,800
Mary B. Jones,
ACF/OPRE Certifying Officer.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–26913 Filed 12–12–19; 8:45 am]
Food and Drug Administration
BILLING CODE 4184–79–P
[Docket No. FDA–2019–D–4751]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Request for Information: Family
Caregiving Advisory Council;
Correction
AGENCY:
Administration for Community
Living, HHS.
Notice of correction.
The Administration for
Community Living (ACL) published a
document in the Federal Register on
December 9, 2019, requesting
information to the Advisory Council to
Support Grandparents Raising
Grandchildren seeking information to be
used in the development of the Initial
Report, as required by the Supporting
Grandparents Raising Grandchildren
Act (SGRG). The ACL wishes to change
a line in the titling of the notice in order
to avoid confusion for potential
commenters.
SUMMARY:
SUPPLEMENTARY INFORMATION:
Correction: In the Federal Register of
December 9, 2019, in FR doc. 2019–
26437, on page 67270, in the second
column, the second line should be
changed to ‘‘Request for Information:
Advisory Council to Support
Grandparents Raising Grandchildren.’’
In addition, the DATES section due date
is incorrect. It should read as follows:
‘‘DATES: Comments on the request for
information must be submitted by 11:59
p.m. (EST) on February 7, 2019.’’
FOR FURTHER INFORMATION CONTACT:
jbell on DSKJLSW7X2PROD with NOTICES
SGRG.Act@acl.hhs.gov
Dated: December 9, 2019.
Lance Robertson,
Administrator and Assistant Secretary for
Aging.
[FR Doc. 2019–26880 Filed 12–12–19; 8:45 am]
BILLING CODE 4154–01–P
VerDate Sep<11>2014
17:42 Dec 12, 2019
Jkt 250001
Food and Drug Administration,
HHS.
AGENCY:
ACTION:
Food and Drug Administration
Reauthorization Act Implementation
Guidance for Pediatric Studies of
Molecularly Targeted Oncology Drugs;
Draft Guidance for Industry;
Availability
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance for industry entitled ‘‘FDARA
Implementation Guidance for Pediatric
Studies of Molecularly Targeted
Oncology Drugs.’’ This draft guidance
addresses early planning for pediatric
evaluation of certain molecularly
targeted oncology drugs, including
biological products, for which original
new drug applications (NDAs) and
biologics license applications (BLAs) are
expected to be submitted to FDA on or
after August 18, 2020, in accordance
with the provisions of the Federal Food,
Drug, and Cosmetic Act (FD&C Act) as
amended by the FDA Reauthorization
Act of 2017 (FDARA). This guidance
addresses the implementation of
amendments made by FDARA to the
FD&C Act regarding molecularly
targeted oncology drugs.
DATES: Submit either electronic or
written comments on the draft guidance
by February 11, 2020 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2019–D–4751 for ‘‘FDARA
Implementation Guidance for Pediatric
Studies of Molecularly Targeted
Oncology Drugs.’’ Received comments
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 84, Number 240 (Friday, December 13, 2019)]
[Notices]
[Pages 68173-68174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-26913]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Generic Program-Specific Performance
Progress Report (0970-0490)
AGENCY: Office of Planning, Research, and Evaluation; Administration
for Children and Families; HHS.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: This Notice describes the proposal to extend data collection
under the Administration for Children and Families (ACF) Generic
Program-Specific Performance Progress Report (PPR) (0970-0490). This
overarching generic allows ACF program offices to collect performance
and progress data from recipients and sub-recipients who receive
funding from ACF under a discretionary grant or cooperative agreement.
This information is required under 45 CFR 75.342, monitoring and
reporting program performance. The generic program-specific PPR was
originally approved in January 2017.
DATES: Comments due within 30 days of publication. OMB is required to
make a decision concerning the collection of information between 30 and
60 days after publication of this document in the Federal Register.
Therefore, a comment is best assured of having its full effect if OMB
receives it within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent directly to the following: Office
of Management and Budget, Paperwork Reduction Project, Email:
[email protected], Attn: Desk Officer for the Administration
for Children and Families.
Copies of the proposed collection may be obtained by emailing
[email protected]. Alternatively, copies can also be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research, and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE Reports Clearance Officer. All
requests, emailed or written, should be identified by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: ACF is primarily a grant-making agency that promotes
the economic and social well-being of families, children, individuals
and communities with partnerships, funding, guidance, training and
technical assistance.
Prior to the use of this generic program-specific PPR, a standard
ACF PPR (#0970-0406) was used for all ACF discretionary grant and
cooperative agreement awards for post award reporting. Historically, on
the standard ACF PPR form, ACF required grantees to only respond to a
common set of broad questions, which often solicited qualitative or
incomplete information. This one-size-fits-all approach did not
adequately collect the specific data needed for particular grant
programs or allow program offices to assess continuous quality
improvement. Different grant programs vary in purpose, target
population, and activities. Therefore, a need for program offices to
customize performance measurements was identified and the generic
program-specific PPR was developed.
ACF program offices have benefited from the ability to create and
use a program-specific PPR that is more effective and includes specific
data elements that reflects a specific program's indicators,
demographics, priorities and objectives. This extension includes
extension of previously approved program-specific PPRs under this OMB
#. A generic program-specific PPR that can be tailored for program-
specific needs allows program offices to collect useful data in a
uniform and systematic manner. The reporting format allows program
offices to gather uniform program performance data from each grantee,
allowing aggregation at the program level to calculate outputs and
outcomes, providing a snapshot and allowing for longitudinal analysis.
Data from a tailored program-specific PPR that demonstrates a
program's successes and challenges have been useful for accountability
purposes, such as required reports to Congress. Moreover, it has been
useful for program management and oversight, such as identifying
grantees' technical assistance needs and ensuring compliance with
Federal and programmatic regulations and policies.
Respondents: ACF Grantees.
[[Page 68174]]
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hour per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
New Program Specific PPRs................... 600 2 4 4,800
----------------------------------------------------------------------------------------------------------------
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2019-26913 Filed 12-12-19; 8:45 am]
BILLING CODE 4184-79-P
